♥

MEDI-CAPS LTD

ISIN : INE442D01010
BSE : 523144
Face Value : 10
Industry : Chemicals

EPS : -1.80
EPS (TTM) : -1.35
Price to Earning (P/E) : -13.39
Book Value : 97.02
Price to Bookvalue (P/B) : 0.25
Dividend Yield : 0 %
Return on Equity (ROE) : -1.87 %
Return on Capital Employed (ROCE) : -1.01 %

MEDI-CAPS LTD share price (02-Apr-2026)
Bombay Stock Exchange BSE
Open / Close	25.5 - 24.1 -5.5 %
Low / High	23.03 - 25.5 10.7 %
Trade Volume	1,672
52 Week Low / High	21 - 46.99 123.8 %

YOU MAY ALSO LIKE

How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
Share Market basics for beginners
Share Market jargons in simple terms
High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
Stock market course tutorial
Stock Market Investment Course explained in simple words.

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR MEDI-CAPS LTD

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	175.54	123.91	153.73	110.38	105.69	63.77	60.29	70.7	78.69	61.94
Total Income	190	126.88	162.71	112.08	108.07	64.45	61.03	71.61	81.12	63.4
Total Expenditure	171.37	115.53	135.96	93.66	97.92	71.05	55.35	63.67	83.74	64.71
Other Income	14.46	2.97	8.98	1.69	2.38	0.68	0.74	0.91	2.43	1.46
Operating Profit	18.63	11.35	26.75	18.42	10.15	-6.6	5.68	7.94	-2.62	-1.31
Interest		0.01
PBDT	18.63	11.34	26.75	18.42	10.15	-6.6	5.68	7.94	-2.62	-1.31
Depreciation	3.93	5.03	5.18	5.03	2.21	4.53	4.53	4.53	3.28	4.26
Profit Before Tax	14.7	6.31	21.57	13.39	7.94	-11.13	1.15	3.41	-5.9	-5.57
Tax	0.14			26.36	4.19			5.06	4.89
Profit After Tax	14.56	6.31	21.57	-12.97	3.75	-11.13	1.15	-1.65	-10.79	-5.57
Net Profit	14.97	5.88	21.43	-13.37	3.61	-11.13	1.15	-1.65	-10.79	-5.57
Equity Capital	124.7	124.7	124.7	124.7	124.7	124.7	124.7	124.7	124.7	124.7
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	1.2	0.47	1.72	-1.07	0.29	-0.89	0.09	-0.13	-0.86	-0.45
Diluted Eps After Extraordinary Items	1.17	0.51	1.73	-1.04	0.3	-0.89	0.09	-0.13	-0.86	-0.45
Diluted Eps Before Extraordinary Items	1.17	0.51	1.73	-1.04	0.3	-0.89	0.09	-0.13	-0.86	-0.45

STANDALONE QUARTERLY RESULT FOR MEDI-CAPS LTD

Date End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales		0.14	0.13	0.13	0.62	0.18	21.31	30.47	19.69	2.9
Total Income	1.43	0.26	6.18	0.14	0.88	0.26	21.31	30.5	21.06	3.97
Total Expenditure	0.72	1.2	0.92	0.91	0.95	3.67	1.59	8.74	9.26	6.9
Other Income	1.43	0.13	6.05	0.01	0.26	0.08		0.02	1.37	1.07
Operating Profit	0.71	-0.94	5.26	-0.77	-0.07	-3.41	19.72	21.76	11.8	-2.93
PBDT	0.71	-0.94	5.26	-0.77	-0.07	-3.41	19.72	21.76	11.8	-2.93
Depreciation	-0.71	0.23	0.23	0.23	0.23	0.4	0.4	0.4	0.4	0.4
Profit Before Tax	1.42	-1.17	5.03	-1	-0.3	-3.81	19.32	21.36	11.4	-3.33
Tax	0.14				-0.01			4.5	4.89
Profit After Tax	1.28	-1.17	5.03	-1	-0.29	-3.81	19.32	16.86	6.51	-3.33
Net Profit	1.69	-1.6	4.89	-1.4	-0.43	-3.81	19.32	16.86	6.51	-3.33
Equity Capital	124.7	124.7	124.7	124.7	124.7	124.7	124.7	124.7	124.7	124.7
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	0.1	-0.09	0.4	-0.08	-0.02	-0.31	1.55	1.35	0.52	-0.27
Diluted Eps After Extraordinary Items	0.1	-0.09	0.4	-0.08	-0.02	-0.31	1.55	1.35	0.52	-0.27
Diluted Eps Before Extraordinary Items	0.1	-0.09	0.4	-0.08	-0.02	-0.31	1.55	1.35	0.52	-0.27

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR MEDI-CAPS LTD

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	698.71	493.71	273.45
Total Income	717.85	509.74	278.2
Total Expenditure	599.15	443.08	273.8
Other Income	19.14	16.03	4.75
Operating Profit	118.7	66.66	4.4
Interest		0.02
PBDT	118.7	66.64	4.4
Depreciation	18.13	17.43	16.87
Profit Before Tax	100.57	49.21	-12.47
Tax	0.14	30.55	9.95
Profit After Tax	100.43	18.66	-22.42
Net Profit	100.8	17.55	-22.42
Equity Capital	124.7	124.7	124.7
Face Value (IN RS)	10	10	10
Reserves	1037.86	1061.01	1085.13
Calculated EPS	8.08	1.41	-1.8
Diluted Eps After Extraordinary Items	8.05	1.5	-1.8
Diluted Eps Before Extraordinary Items	8.05	1.5	-1.8

STANDALONE ANNUAL RESULT FOR MEDI-CAPS LTD

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales		1.01	71.65
Total Income	6.07	7.46	73.13
Total Expenditure	5.76	3.98	23.25
Other Income	6.07	6.45	1.47
Operating Profit	0.31	3.48	49.88
PBDT	0.31	3.48	49.88
Depreciation	0.92	0.92	1.6
Profit Before Tax	-0.61	2.56	48.28
Tax	0.14	-0.01	9.39
Profit After Tax	-0.75	2.57	38.89
Net Profit	-0.38	1.46	38.89
Equity Capital	124.7	124.7	124.7
Face Value (IN RS)	10	10	10
Reserves	488.18	486.38	540.19
Calculated EPS	-0.06	0.21	3.12
Diluted Eps After Extraordinary Items	-0.06	0.21	3.12
Diluted Eps Before Extraordinary Items	-0.06	0.21	3.12

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR MEDI-CAPS LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	58.16 Cr	69.87 Cr	49.37 Cr	27.35 Cr
Sales	58.16 Cr	68.31 Cr	48.58 Cr	19.63 Cr
Revenue from property development	0	0	0	6.93 Cr
Net Sales	58.16 Cr	69.87 Cr	49.37 Cr	27.35 Cr
Increase/Decrease in Stock	-1.24 Cr	6.43 Lk	85.21 Lk	1.09 Cr
Raw Material Consumed	27.78 Cr	27.56 Cr	20.35 Cr	7.67 Cr
Opening Raw Materials	2.63 Cr	2.68 Cr	7.76 Cr	4.06 Cr
Purchases Raw Materials	27.83 Cr	32.64 Cr	16.65 Cr	7.31 Cr
Closing Raw Materials	2.68 Cr	7.76 Cr	4.06 Cr	3.71 Cr
Power & Fuel Cost	2.65 Cr	3.35 Cr	2.25 Cr	1.55 Cr
Electricity & Power	2.65 Cr	3.35 Cr	2.25 Cr	1.55 Cr
Employee Cost	5.12 Cr	5.62 Cr	5.65 Cr	5.21 Cr
Salaries, Wages & Bonus	4.7 Cr	4.91 Cr	5.15 Cr	4.88 Cr
Contributions to EPF & Pension Funds	29.42 Lk	34.12 Lk	33.56 Lk	27.72 Lk
Workmen and Staff Welfare Expenses	2.26 Lk	1.74 Lk	2.52 Lk	1.6 Lk
Other Manufacturing Expenses	6.41 Cr	5.36 Cr	4.33 Cr	3.15 Cr
Repairs and Maintenance	1.38 Cr	1.15 Cr	85.19 Lk	94.56 Lk
Packing Material Consumed	3.29 Cr	2.49 Cr	1.7 Cr	75.84 Lk
General and Administration Expenses	2.87 Cr	3.33 Cr	4.2 Cr	5.14 Cr
Rent , Rates & Taxes	3.71 Lk	3.19 Lk	3.48 Lk	4.57 Lk
Insurance	22.63 Lk	11.68 Lk	16.45 Lk	15.96 Lk
Printing and stationery	10.67 Lk	14.36 Lk	11.18 Lk	8.01 Lk
Professional and legal fees	28.81 Lk	35.41 Lk	68.16 Lk	2.28 Cr
Traveling and conveyance	12.3 Lk	34.75 Lk	90.22 Lk	47 Lk
Selling and Distribution Expenses	2.51 Cr	13.14 Cr	5.69 Cr	2.77 Cr
Advertisement & Sales Promotion	77.04 Lk	1.39 Cr	64.17 Lk	77.22 Lk
Sales Commissions & Incentives	0	0	0	46.16 Lk
Freight and Forwarding	1.62 Cr	11.63 Cr	5.05 Cr	1.54 Cr
Miscellaneous Expenses	1.59 Cr	1.38 Cr	85.3 Lk	75.81 Lk
Bad debts /advances written off	3.74 Lk	0	0	0
Total Expenditure	47.69 Cr	59.81 Cr	44.18 Cr	27.34 Cr
Other Income	2.62 Cr	1.91 Cr	1.6 Cr	47.5 Lk
Interest Received	34.02 Lk	52.99 Lk	0	0
Dividend Received	0	0	28,000	44,000
Profit on sale of Fixed Assets	0	4.74 Lk	0	0
Foreign Exchange Gains	58.37 Lk	85.89 Lk	88.77 Lk	27.85 Lk
Operating Profit	13.08 Cr	11.98 Cr	6.79 Cr	47.71 Lk
Interest	10.6 Lk	10.82 Lk	12.79 Lk	3.66 Lk
Bank Charges etc	10.29 Lk	9.85 Lk	12.63 Lk	3.66 Lk
PBDT	12.98 Cr	11.87 Cr	6.66 Cr	44.05 Lk
Depreciation	1.85 Cr	1.81 Cr	1.74 Cr	1.69 Cr
Profit Before Taxation & Exceptional Items	11.12 Cr	10.06 Cr	4.92 Cr	-1.25 Cr
Profit Before Tax	11.12 Cr	10.06 Cr	4.92 Cr	-1.25 Cr
Provision for Tax	-51,389	1.44 Lk	3.05 Cr	99.48 Lk
Current Income Tax	0	0	1.22 Cr	95 Lk
Deferred Tax	-51,389	1.44 Lk	-14,000	-1.09 Lk
Profit After Tax	11.13 Cr	10.04 Cr	1.87 Cr	-2.24 Cr
Extra items	2.63 Cr	3.72 Lk	-11.07 Lk	0
Consolidated Net Profit	13.76 Cr	10.08 Cr	1.76 Cr	-2.24 Cr
Profit Balance B/F	42.43 Cr	56.19 Cr	62.44 Cr	64.19 Cr
Appropriations	56.19 Cr	66.27 Cr	64.19 Cr	61.95 Cr
Other Appropriation	0	-1.46 Cr	0	0
Earnings Per Share	8.92	8.08	1.41	-1.8
Adjusted EPS	8.92	8.08	1.41	-1.8

STANDALONE PROFIT / LOSS FOR MEDI-CAPS LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	74.16 Lk	0	10.13 Lk	7.17 Cr
Sales	74.16 Lk	0	0	0
Revenue from property development	0	0	0	6.93 Cr
Net Sales	74.16 Lk	0	10.13 Lk	7.17 Cr
Increase/Decrease in Stock	47.8 Lk	0	0	1.2 Lk
Power & Fuel Cost	1.03 Lk	0	21,000	43,000
Electricity & Power	1.03 Lk	0	21,000	43,000
Employee Cost	16.47 Lk	45.13 Lk	23.26 Lk	49.51 Lk
Salaries, Wages & Bonus	16.47 Lk	28.4 Lk	22.9 Lk	49.46 Lk
Workmen and Staff Welfare Expenses	0	0	36,000	5,000
Other Manufacturing Expenses	13.73 Lk	1.19 Lk	44,000	11.89 Lk
Repairs and Maintenance	12.9 Lk	0	0	1,000
General and Administration Expenses	16.25 Lk	9.51 Lk	12.28 Lk	1.26 Cr
Rent , Rates & Taxes	1.51 Lk	98,000	1.27 Lk	2.36 Lk
Insurance	1.87 Lk	4,000	1.31 Lk	1.47 Lk
Printing and stationery	12,690	15,000	18,000	3,000
Professional and legal fees	9.82 Lk	7.54 Lk	7.78 Lk	56.95 Lk
Traveling and conveyance	2.29 Lk	15,000	1.05 Lk	23.9 Lk
Selling and Distribution Expenses	38,033	62,000	42,000	39.84 Lk
Advertisement & Sales Promotion	32,833	62,000	42,000	39.84 Lk
Freight and Forwarding	5,200	0	0	0
Miscellaneous Expenses	29.9 Lk	3,000	2.84 Lk	3.73 Lk
Bad debts /advances written off	44,788	0	0	0
Total Expenditure	1.26 Cr	56.48 Lk	39.45 Lk	2.33 Cr
Other Income	73.25 Lk	60.74 Lk	64.46 Lk	14.72 Lk
Interest Received	0	5.42 Lk	0	0
Profit on sale of Fixed Assets	0	4.74 Lk	0	0
Operating Profit	21.85 Lk	4.26 Lk	35.14 Lk	4.99 Cr
Interest	33,227	1.11 Lk	33,000	1,000
Bank Charges etc	2,397	16,000	33,000	1,000
PBDT	21.52 Lk	3.15 Lk	34.81 Lk	4.99 Cr
Depreciation	33.11 Lk	9.23 Lk	9.23 Lk	16.01 Lk
Profit Before Taxation & Exceptional Items	-11.59 Lk	-6.08 Lk	25.58 Lk	4.83 Cr
Profit Before Tax	-11.59 Lk	-6.08 Lk	25.58 Lk	4.83 Cr
Provision for Tax	-51,389	1.44 Lk	-14,000	93.91 Lk
Current Income Tax	0	0	0	95 Lk
Deferred Tax	-51,389	1.44 Lk	-14,000	-1.09 Lk
Profit After Tax	-11.08 Lk	-7.52 Lk	25.72 Lk	3.89 Cr
Extra items	1.23 Cr	3.71 Lk	-11.07 Lk	0
Consolidated Net Profit	1.12 Cr	-3.81 Lk	14.65 Lk	3.89 Cr
Profit Balance B/F	43.96 Cr	45.08 Cr	43.14 Cr	43.29 Cr
Appropriations	45.08 Cr	45.04 Cr	43.29 Cr	47.18 Cr
Other Appropriation	0	-35.69 Lk	0	0
Earnings Per Share	-0.09	-0.06	0.21	3.12
Adjusted EPS	-0.09	-0.06	0.21	3.12

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR MEDI-CAPS LTD

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	11.24 Cr	10.09 Cr	4.92 Cr	-1.25 Cr
Adjustment	4.37 Cr	3.37 Cr	2.26 Cr	6.33 Cr
Changes In working Capital	-28.61 Lk	-6.44 Cr	-10.2 Cr	2.86 Cr
Cash Flow after changes in Working Capital	15.32 Cr	7.02 Cr	-3.03 Cr	7.94 Cr
Cash Flow from Operating Activities	15.32 Cr	7.02 Cr	-6.08 Cr	6.94 Cr
Cash Flow from Investing Activities	-9.7 Cr	-4.08 Cr	-2.56 Cr	-7.73 Cr
Cash Flow from Financing Activitie	-6.35 Lk	0	0	0
Net Cash Inflow / Outflow	5.56 Cr	2.95 Cr	-8.64 Cr	-79.21 Lk
Opening Cash & Cash Equivalents	1.25 Cr	6.81 Cr	9.75 Cr	1.11 Cr
Closing Cash & Cash Equivalent	6.81 Cr	9.75 Cr	1.11 Cr	32.14 Lk

STANDALONE CASH FLOW FOR MEDI-CAPS LTD

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	0	-2.36 Lk	25.58 Lk	4.83 Cr
Adjustment	1.45 Cr	53.88 Lk	-27.76 Lk	1.65 Cr
Changes In working Capital	78.55 Lk	-1.47 Cr	-2.57 Cr	-2.44 Cr
Cash Flow after changes in Working Capital	2.24 Cr	-95.08 Lk	-2.6 Cr	4.04 Cr
Cash Flow from Operating Activities	2.24 Cr	-95.08 Lk	-2.6 Cr	3.09 Cr
Cash Flow from Investing Activities	-2.19 Cr	1.01 Cr	1.85 Cr	-3.09 Cr
Cash Flow from Financing Activitie	-6.35 Lk	0	0	0
Net Cash Inflow / Outflow	-1.73 Lk	5.89 Lk	-74.62 Lk	49,000
Opening Cash & Cash Equivalents	74.52 Lk	72.79 Lk	78.67 Lk	4.05 Lk
Closing Cash & Cash Equivalent	72.79 Lk	78.68 Lk	4.05 Lk	4.54 Lk

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR MEDI-CAPS LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	12.47 Cr	12.47 Cr	12.47 Cr	12.47 Cr
Equity - Authorised	15 Cr	15 Cr	15 Cr	15 Cr
Equity - Issued	12.47 Cr	12.47 Cr	12.47 Cr	12.47 Cr
Equity Paid Up	12.47 Cr	12.47 Cr	12.47 Cr	12.47 Cr
Face Value	10	10	10	10
Total Reserves	92.24 Cr	103.79 Cr	106.1 Cr	108.51 Cr
Securities Premium	32.63 Cr	32.63 Cr	32.63 Cr	32.63 Cr
Capital Reserves	37.45 Lk	37.45 Lk	37.45 Lk	37.45 Lk
Profit & Loss Account Balance	56.19 Cr	67.73 Cr	64.19 Cr	61.95 Cr
General Reserves	3.05 Cr	3.05 Cr	3.05 Cr	3.05 Cr
Reserve excluding Revaluation Reserve	92.24 Cr	103.79 Cr	106.1 Cr	108.51 Cr
Shareholder's Funds	104.71 Cr	116.26 Cr	118.57 Cr	120.98 Cr
Deferred Tax Assets / Liabilities	42.69 Lk	44.13 Lk	43.98 Lk	42.89 Lk
Deferred Tax Liability	42.69 Lk	44.13 Lk	43.98 Lk	42.89 Lk
Long Term Provisions	40.91 Lk	45.34 Lk	1.81 Cr	61.31 Lk
Total Non-Current Liabilities	83.6 Lk	89.47 Lk	2.25 Cr	1.04 Cr
Trade Payables	6.16 Cr	11.68 Cr	2.83 Cr	1.83 Cr
Sundry Creditors	6.16 Cr	11.68 Cr	2.83 Cr	1.83 Cr
Other Current Liabilities	3.12 Cr	1.52 Cr	2.34 Cr	2.48 Cr
Advances received from customers	1.13 Cr	48.38 Lk	1.32 Cr	1.57 Cr
Short Term Provisions	0	0	0	95 Lk
Provision for Tax	0	0	0	95 Lk
Total Current Liabilities	9.27 Cr	13.2 Cr	5.17 Cr	5.26 Cr
Total Liabilities	114.82 Cr	130.35 Cr	125.99 Cr	127.28 Cr
Gross Block	90.28 Cr	92.53 Cr	91.09 Cr	91.43 Cr
Less: Accumulated Depreciation	32.16 Cr	33.22 Cr	32.18 Cr	33.87 Cr
Net Block	58.12 Cr	59.31 Cr	58.91 Cr	57.57 Cr
Capital Work in Progress	54.22 Lk	24.34 Lk	0	0
Non Current Investments	3.12 Cr	2.64 Cr	6.49 Cr	9.32 Cr
Long Term Investment	3.12 Cr	2.64 Cr	6.49 Cr	9.32 Cr
Quoted	1.57 Cr	2.17 Cr	4.78 Cr	7.54 Cr
Unquoted	1.55 Cr	47.01 Lk	1.71 Cr	1.78 Cr
Long Term Loans & Advances	36.59 Lk	38.69 Lk	38.58 Lk	38.73 Lk
Total Non-Current Assets	62.15 Cr	63.66 Cr	65.78 Cr	67.27 Cr
Currents Investments	26.3 Cr	26.96 Cr	25.59 Cr	30.14 Cr
Quoted	26.3 Cr	26.96 Cr	24.34 Cr	28.89 Cr
Unquoted	1.55 Cr	47.01 Lk	1.71 Cr	1.78 Cr
Inventories	6.71 Cr	11.85 Cr	7.07 Cr	5.74 Cr
Raw Materials	2.68 Cr	7.76 Cr	4.06 Cr	3.71 Cr
Finished Goods	3.85 Cr	3.79 Cr	2.94 Cr	1.89 Cr
Packing Materials	13.11 Lk	30.06 Lk	6.92 Lk	13.96 Lk
Stores and Spare	4.46 Lk	0	0	0
Sundry Debtors	6.39 Cr	10.07 Cr	8.46 Cr	10.82 Cr
Debtors more than Six months	5.97 Cr	2.24 Cr	3.81 Cr	6.51 Cr
Debtors Others	42.03 Lk	7.83 Cr	4.66 Cr	4.31 Cr
Cash and Bank	6.81 Cr	9.75 Cr	1.11 Cr	32.14 Lk
Cash in hand	22,174	28,000	55,000	70,000
Balances at Bank	6.81 Cr	9.75 Cr	1.11 Cr	31.44 Lk
Other Current Assets	18.63 Lk	21.35 Lk	23.02 Lk	25.51 Lk
Interest accrued and or due on loans	0	0	0	3.02 Lk
Prepaid Expenses	11.3 Lk	14.01 Lk	15.68 Lk	16.63 Lk
Short Term Loans and Advances	6.28 Cr	7.84 Cr	17.74 Cr	12.74 Cr
Advances recoverable in cash or in kind	1.58 Cr	1.46 Cr	2.48 Cr	2.31 Cr
Advance income tax and TDS	1.69 Cr	1.7 Cr	3.05 Cr	3.16 Cr
Total Current Assets	52.67 Cr	66.69 Cr	60.2 Cr	60.01 Cr
Net Current Assets (Including Current Investments)	43.4 Cr	53.49 Cr	55.04 Cr	54.75 Cr
Total Assets	114.82 Cr	130.35 Cr	125.99 Cr	127.28 Cr
Contingent Liabilities	2 Cr	2 Cr	0	0
Book Value	0	93.23	95.09	0
Adjusted Book Value	83.97	93.23	95.09	97.02

STANDALONE BALANCE SHEET FOR MEDI-CAPS LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	12.47 Cr	12.47 Cr	12.47 Cr	12.47 Cr
Equity - Authorised	15 Cr	15 Cr	15 Cr	15 Cr
Equity - Issued	12.47 Cr	12.47 Cr	12.47 Cr	12.47 Cr
Equity Paid Up	12.47 Cr	12.47 Cr	12.47 Cr	12.47 Cr
Face Value	10	10	10	10
Total Reserves	48.5 Cr	48.82 Cr	48.64 Cr	54.02 Cr
Capital Reserves	37.45 Lk	37.45 Lk	37.45 Lk	37.45 Lk
Profit & Loss Account Balance	45.08 Cr	45.4 Cr	43.29 Cr	47.18 Cr
General Reserves	3.05 Cr	3.05 Cr	3.05 Cr	3.05 Cr
Reserve excluding Revaluation Reserve	48.5 Cr	48.82 Cr	48.64 Cr	54.02 Cr
Shareholder's Funds	60.97 Cr	61.29 Cr	61.11 Cr	66.49 Cr
Deferred Tax Assets / Liabilities	42.69 Lk	44.13 Lk	43.98 Lk	42.89 Lk
Deferred Tax Liability	42.69 Lk	44.13 Lk	43.98 Lk	42.89 Lk
Long Term Provisions	13.48 Lk	0	0	0
Total Non-Current Liabilities	56.17 Lk	44.13 Lk	43.98 Lk	42.89 Lk
Trade Payables	3.47 Lk	5,000	0	50,000
Sundry Creditors	3.47 Lk	5,000	0	50,000
Other Current Liabilities	1.07 Cr	7.58 Lk	7.8 Lk	21.9 Lk
Advances received from customers	0	0	0	10 Lk
Short Term Provisions	0	0	0	95 Lk
Provision for Tax	0	0	0	95 Lk
Total Current Liabilities	1.11 Cr	7.63 Lk	7.8 Lk	1.17 Cr
Total Liabilities	62.64 Cr	61.81 Cr	61.63 Cr	68.09 Cr
Gross Block	21.13 Cr	19.99 Cr	16.99 Cr	16.95 Cr
Less: Accumulated Depreciation	17.88 Cr	17.22 Cr	14.53 Cr	14.69 Cr
Net Block	3.26 Cr	2.78 Cr	2.46 Cr	2.26 Cr
Non Current Investments	44.1 Cr	42.83 Cr	43.91 Cr	43.91 Cr
Long Term Investment	44.1 Cr	42.83 Cr	43.91 Cr	43.91 Cr
Quoted	10,755	46,000	39,000	30,000
Unquoted	44.1 Cr	42.82 Cr	43.9 Cr	43.9 Cr
Long Term Loans & Advances	5.15 Lk	5.02 Lk	4.91 Lk	4.93 Lk
Total Non-Current Assets	47.4 Cr	46.73 Cr	46.42 Cr	46.22 Cr
Currents Investments	10.29 Cr	9.77 Cr	8.07 Cr	11.2 Cr
Quoted	10.29 Cr	9.77 Cr	8.07 Cr	11.2 Cr
Unquoted	44.1 Cr	42.82 Cr	43.9 Cr	43.9 Cr
Inventories	4.94 Lk	0	0	3.16 Lk
Finished Goods	0	0	0	3.16 Lk
Packing Materials	47,491	0	0	0
Stores and Spare	4.46 Lk	0	0	0
Sundry Debtors	2.41 Cr	2.24 Cr	2.24 Cr	4.65 Cr
Debtors more than Six months	1.99 Cr	2.24 Cr	2.24 Cr	2.24 Cr
Debtors Others	42.03 Lk	34,000	0	2.41 Cr
Cash and Bank	72.79 Lk	78.67 Lk	4.04 Lk	4.54 Lk
Cash in hand	20,451	9,000	9,000	8,000
Balances at Bank	72.59 Lk	78.58 Lk	3.95 Lk	4.46 Lk
Other Current Assets	7.34 Lk	7.34 Lk	7.34 Lk	5.89 Lk
Interest accrued and or due on loans	0	0	0	2,000
Short Term Loans and Advances	1.68 Cr	2.2 Cr	4.78 Cr	5.89 Cr
Advances recoverable in cash or in kind	0	51 Lk	2.11 Cr	1.9 Cr
Advance income tax and TDS	1.68 Cr	1.69 Cr	1.95 Cr	3.01 Cr
Total Current Assets	15.23 Cr	15.07 Cr	15.2 Cr	21.88 Cr
Net Current Assets (Including Current Investments)	14.13 Cr	15 Cr	15.13 Cr	20.7 Cr
Total Assets	62.64 Cr	61.81 Cr	61.63 Cr	68.09 Cr
Contingent Liabilities	2 Cr	2 Cr	2 Cr	0
Book Value	48.89	49.15	49	0
Adjusted Book Value	48.89	49.15	49	53.32

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR MEDI-CAPS LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	8.92	8.08	1.41	-1.8
CEPS(Rs)	10.41	9.51	2.89	-0.44
Book NAV/Share(Rs)	83.97	93.23	95.09	97.02
Tax Rate(%)	-0.05	0.14	62.07	-79.84
Margin Ratios
Core EBITDA Margin(%)	17.99	14.41	10.51	0.01
EBIT Margin(%)	19.31	14.55	10.23	-4.42
Pre Tax Margin(%)	19.13	14.39	9.97	-4.56
PAT Margin (%)	19.14	14.37	3.78	-8.19
Cash Profit Margin (%)	22.32	16.97	7.31	-2.03
Performance Ratios
ROA(%)	10.6	8.19	1.46	-1.77
ROE(%)	11.38	9.09	1.59	-1.87
ROCE(%)	11.47	9.2	4.3	-1.01
Asset Turnover(x)	0.55	0.57	0.39	0.22
Sales/Fixed Asset(x)	0.65	0.76	0.54	0.3
Working Capital/Sales(x)	1.34	1.31	0.9	0.5
Efficiency Ratios
Fixed Capital/Sales(x)	1.53	1.31	1.86	3.34
Receivable days	33.87	42.99	68.52	128.69
Inventory Days	38.13	48.47	69.93	85.46
Payable days	55.7	117.84	124.89	96.98
Valuation Parameters
PER(x)	4.52	6.14	24.81	0
PCE(x)	3.88	5.22	12.07	-99.73
Price/Book(x)	0.48	0.53	0.37	0.46
EV/Net Sales(x)	0.75	0.75	0.86	2.01
EV/Core EBITDA(x)	3.33	4.35	6.25	115.19
EV/EBIT(x)	3.87	5.13	8.41	-45.44
EV/CE(x)	0.38	0.4	0.34	0.45
M Cap / Sales	0.87	0.89	0.88	2.02
Growth Ratio
Net Sales Growth(%)	35.09	18.99	-29.34	-44.61
Core EBITDA Growth(%)	435.76	-6.88	-43.3	-92.98
EBIT Growth(%)	296.11	-10.37	-50.34	-123.96
PAT Growth(%)	290.18	-10.69	-81.42	-220.06
EPS Growth(%)	290.18	-9.42	-82.58	-227.64
Financial Stability Ratios
Current Ratio(x)	5.68	5.05	11.65	11.41
Quick Ratio(x)	4.96	4.15	10.28	10.32
Interest Cover(x)	105.92	93.95	39.47	-33.04

FINANCIAL RATIOS (STANDALONE) FOR MEDI-CAPS LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	-0.09	-0.06	0.21	3.12
CEPS(Rs)	0.18	0.01	0.28	3.25
Book NAV/Share(Rs)	48.89	49.15	49	53.32
Tax Rate(%)	4.43	-23.68	-0.55	19.45
Margin Ratios
Core EBITDA Margin(%)	-69.3	0	-289.44	67.55
EBIT Margin(%)	-15.18	0	255.78	67.37
Pre Tax Margin(%)	-15.63	0	252.52	67.37
PAT Margin (%)	-14.94	0	253.9	54.26
Cash Profit Margin (%)	29.71	0	345.02	56.5
Performance Ratios
ROA(%)	-0.18	-0.12	0.42	5.99
ROE(%)	-0.18	-0.12	0.42	6.09
ROCE(%)	-0.19	-0.08	0.42	7.57
Asset Turnover(x)	0.01	0	0	0.11
Sales/Fixed Asset(x)	0.03	0	0.01	0.42
Working Capital/Sales(x)	0.05	0	0.01	0.35
Efficiency Ratios
Fixed Capital/Sales(x)	28.84	0	182.57	2.37
Receivable days	1249.02	0	8070.72	175.45
Inventory Days	143.22	0	0	1.61
Payable days	174.45	0	0	152.08
Valuation Parameters
PER(x)	0	0	169.32	14.22
PCE(x)	228.37	3620.68	124.63	13.66
Price/Book(x)	0.83	1.01	0.71	0.83
EV/Net Sales(x)	66.86	0	429.59	7.71
EV/Core EBITDA(x)	226.94	1434.9	123.84	11.07
EV/EBIT(x)	-440.37	-1229.92	167.96	11.44
EV/CE(x)	0.79	0.99	0.71	0.83
M Cap / Sales	67.85	0	429.99	7.71
Growth Ratio
Net Sales Growth(%)	-93.2	0	0	6966.47
Core EBITDA Growth(%)	102.75	0	724.88	1319.32
EBIT Growth(%)	98.64	0	621.33	1763.14
PAT Growth(%)	98.67	-1574.51	442.02	1411.74
EPS Growth(%)	98.67	-1574.39	442.12	1411.39
Financial Stability Ratios
Current Ratio(x)	13.78	197.55	194.93	18.63
Quick Ratio(x)	13.73	197.55	194.93	18.61
Interest Cover(x)	-33.89	-4.48	78.52	0

SHARE HOLDING PATTERN FOR MEDI-CAPS LTD

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	50.13	50.13	50.13	50.13	50.13	50.13	50.13	50.13	50.13	50.43
FII %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
DII %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public %	49.84	49.84	49.84	49.84	49.84	49.84	49.84	49.84	49.84	49.54

PEER COMPARISON FOR MEDI-CAPS LTD

No.	Name
1	ANDHRA PETROCHEMICALS LTD
2	Atul Limited
3	Bhansali Engineering Polymers Limited
4	Oriental Aromatics Limited
5	DIC India Limited
6	DCW Limited
7	ELANTAS BECK INDIA LTD
8	Foseco India Limited
9	Ganesh Benzoplast Limited
10	FUTURISTIC OFFSHORE SERVICES & CHEMICAL LTD
11	Godrej Industries Limited
12	GHCL Limited
13	GFL Limited
14	Himadri Speciality Chemical Limited
15	IG Petrochemicals Limited
16	India Glycols Limited
17	INSILCO LTD
18	Manali Petrochemicals Limited
19	Lords Chloro Alkali Limited
20	NATIONAL PEROXIDE LTD
21	Pidilite Industries Limited
22	Supreme Petrochem Limited
23	Thirumalai Chemicals Limited
24	HINDUSTAN ORGANIC CHEMICALS LTD
25	NOCIL Limited
26	Tata Chemicals Limited
27	INDOKEM LTD
28	Grauer & Weil (India) Limited
29	Styrenix Performance Materials Limited
30	Chemplast Sanmar Limited
31	CITURGIA BIOCHEMICALS LTD
32	Heubach Colorants India Limited
33	Deepak Nitrite Limited
34	DMCC SPECIALITY CHEMICALS LIMITED
35	GOCL Corporation Limited
36	Kanoria Chemicals & Industries Limited
37	NITTA GELATIN INDIA LTD
38	Oriental Carbon & Chemicals Limited
39	POLYCHEM LTD
40	TECIL CHEMICALS & HYDRO POWER LTD
41	ULTRAMARINE & PIGMENTS LTD
42	MYSORE PETRO CHEMICALS LTD
43	TUTICORIN ALKALI CHEMICALS & FERTILISERS LTD
44	PUNJAB ALKALIES & CHEMICALS LTD
45	TANFAC INDUSTRIES LTD
46	IVP Limited
47	TGV Sraac Ltd
48	Vishnu Chemicals Limited
49	Vikas WSP Limited
50	MEDI-CAPS LTD

CORPORATE ACTIONS FOR MEDI-CAPS LTD

Exchange Date	Purpose	Book Closure Dates
BSE 01-Aug-2024	Board Meeting - Quarterly Results	07-Aug-2024
BSE 15-May-2024	Board Meeting - Quarterly Results	23-May-2024
BSE 31-Jan-2024	Board Meeting - Quarterly Results	08-Feb-2024
BSE 01-Nov-2023	Board Meeting - Quarterly Results	08-Nov-2023
BSE 12-Sep-2023	Book Closure - A.G.M.	23-Sep-2023 29-Sep-2023
BSE 12-Sep-2023	AGM - A.G.M.	29-Sep-2023 29-Sep-2023
BSE 04-Aug-2023	Board Meeting - Quarterly Results	11-Aug-2023
BSE 15-May-2023	Board Meeting - Quarterly Results	23-May-2023
BSE 01-Feb-2023	Board Meeting - Quarterly Results	09-Feb-2023
BSE 03-Nov-2022	Board Meeting - Quarterly Results	10-Nov-2022
BSE 05-Aug-2022	Book Closure - A.G.M.	22-Sep-2022 28-Sep-2022
BSE 04-Aug-2022	AGM - Inter alia, approved: 1. Approval of appointment of Mr. Akshit Garg (DIN: 08576807) as an additional director under the category of Promoter Non Executive Director of the Company subject to approval of members in ensuing Annual General Meeting. 2. Approval of appointment of Mr. Sourabh Kumar Shrivas (DIN: 09692160) as an additional director under the category of Non Executive Independent Director ...	28-Sep-2022
BSE 26-Jul-2022	Board Meeting - Quarterly Results	04-Aug-2022
BSE 17-May-2022	Board Meeting - Quarterly Results & Audited Results	25-May-2022
BSE 02-Feb-2022	Board Meeting - Quarterly Results	10-Feb-2022
BSE 01-Nov-2021	Board Meeting - Quarterly Results	10-Nov-2021

CORPORATE ANNOUNCEMENTS FOR MEDI-CAPS LTD

Exchange Date	Category File	Description
BSE 07-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate for compliance of Regulation 74(5) of SEBI (DP) regulation for the quarter and half year ended 30.09.2024
BSE 03-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Registered Office Address This is inform you that members of the Company in their Annual General Meeting have accorded their consent to sift the registered office of company.
BSE 27-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Voting result of 41st Annual General Meeting
BSE 26-Sep-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Outcome of AGM Proceeding of 41st AGM of Medicaps Limiited Held on 26.09.2024
BSE 26-Sep-2024	Intimation FILE	Closure of Trading Window The Trading window shall remain closed for trading of shares of the company from 01.10.2024 till completion of 48 hours of declaration of unaudited results for the quarter and half year ended on 30.09.2024
BSE 04-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 30 40 and 47 of LODR and compliance with section 108 of the Companies Act 2013 read with rule 20 Companies ( Management and Administration) Rule 2014 we hereby enclosing extracts of news paper i.e. Free Press Journal (English edition) and Choutha sansar (Hindi edition) published after dispatch of notice.
BSE 02-Sep-2024	General Announcements FILE	ANNOUNCEMENT UNDER REGULATION 44 OF SEBI (LODR) REGULATION 2015 ANNOUNCEMENT UNDER REGULATION 44 OF SEBI (LODR) REGULATION 2015
BSE 02-Sep-2024	General Announcements FILE	BOOK CLOSURE FOR 41ST ANNUAL GENERAL MEETING OF THE COMPANY. BOOK CLOSURE FOR 41ST ANNUAL GENERAL MEETING OF THE COMPANY.
BSE 02-Sep-2024	General Announcements FILE	Reg. 34 (1) Annual Report. SUBMISSION OF 41ST ANNUAL REPORT.
BSE 02-Sep-2024	Intimation FILE	Submission Of Notice Convening The 41St Annual General Meeting. Submission of notice convening the 41st Annual General Meeting.
BSE 29-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication submission of extract of news paper advertisement dated 29.08.2024 published in Free Press Journal (English edition) and Chuotha Sansar (Hindi edition) regarding information of 41st Annual General Meeting.
BSE 09-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Extract of Un-audited standalone and consolidated financial results of the the company for the quarter ended 30.06.2024 published in free press English edition and choutha sansar Hindi edition dated 09.08.2024. Copy of the newspaper attached herewith.
BSE 07-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Registered Office Address The Board of Directors of the company in their meeting dated 07.08.2024 has inter alia considered and approve the shifting of registered office outside the local limit of city town or village subject to approval of members in ensuing 41st Annual General meeting of the Company.
BSE 07-Aug-2024	Outcome FILE	Submission Of Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended On 30Th June 2024 Along With Limited Review Report Thereon. Submission of un-audited standalone and consolidated financial results of the Company for the quarter ended on 30.06.2024 along with Limited Review Report thereon.
BSE 07-Aug-2024	Outcome FILE	Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 07TH AUGUST 2024 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015. The Board of Directors at their meeting held on Wednesday i.e. 07th August 2024 has inter alia considered and approved the following businesses:(1) Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June 2024 along with Limited Review Report thereon.(2) Boards Report on the operations of the Company along with required annexure and Corporate Governance Report and Management Discussion and Analysis Report for the year ended 31st March 2024.(3) Continuation of directorship of Mrs. Kusum Mittal (DIN: 00035356) on attaining the age of 75 (seventy-five) years.(4) Convening of 41st Annual General Meeting (AGM) (5) Change of Registered Office outside the local limits of city town or village w.e.f. 01st October 2024 subject to approval of members in ensuing 41st Annual General Meeting.(6) Other routine businesses with the permission of chair.
BSE 01-Aug-2024	Intimation FILE	Board Meeting Intimation for Meeting Of Board Of Directors (Serial No. 02/2024-25) Of The Company Scheduled To Be Held On Wednesday 7Th Day Of August 2024 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve 1.To consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter ended on 30th June 2024 along with the Limited Review Report thereon. 2.Other routine matters with the permission of chair.
BSE 10-Jul-2024	General FILE	Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Dheeraj Kumar Lohia & PACs
BSE 06-Jul-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 certificate for compliance of Regulation 74(5) of SEBI (Depositories and Participants ) Regulation 2018 for the quarter ended 30.06.2024.
BSE 27-Jun-2024	Intimation FILE	Closure of Trading Window The Trading window shall remain closed trading of shares of the company from 01.07.2024 till completion of 48 hours of declaration of unaudited financial result for the quarter ended on 30.06.2024
BSE 14-Jun-2024	General Announcements FILE	Intimation To The Holders Of Physical Shares In Terms Of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod-1/P/CIR/2023/37 Dated March 16 2023 Regarding Mandatory Furnishing Of PAN KYC Details And Nomination. In term of regulation 30 of SEBI ( LODR) Regulation 2015 and term of SEBI circular dated March 16 2023 please find enclosed copy of letter to be sent to physical shareholder for updating KYC PAN etc.
BSE 07-Jun-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate The RTA of the Company has issued letter of confirmation in lieu of original share certificate after completing all the formalities.
BSE 29-May-2024	Compliance FILE	Compliances-Reg.24(A)-Annual Secretarial Compliance Pursuant Regulation 24 (A) SEBI (LODR) Regulation 2015 please find enclosed herewith Annual Secretarial Compliance Report of the company for the Financial Year 31.03.2024 .
BSE 28-May-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Continuous Disclosure under regulation 30 of SEBI (LODR) Regulation 2015 for completion of final and second term of Independent Director Mr. Pramod Fatehpuria (DIN: 00972389).
BSE 25-May-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Standalone and Consolidated Audited Financial Results for the quarter and year ended on 31.03.2024 were approved by the Board in their 01/2024-2025 Board Meeting held on 23rd May 2024. An extract of the same published in Free Press Journal English edition and Choutha Sansar Hindi edition on 25.05.2024. Copy of the same being enclosed.
BSE 23-May-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Re-appointment of Secretarial auditor for the financial year 2024-25
BSE 23-May-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Re-appointment of Internal auditor for the Financial year 2024-25
BSE 23-May-2024	Outcome FILE	Board Meeting Outcome for Outcome For The Meeting Of Board Of Directors Held On 23.05.2024 The Board of directors of the company at its meeting held on 23.05.2024 inter alia considered and approved the matter as mentioned in the letter.
BSE 23-May-2024	Outcome FILE	Outcome Of Board Meeting Held On Thursday 23Rd May 2024 Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015. The Board of Directors of the company in their meeting held on 23rd May 2024 has inter alia considered and approved the following businesses: 1. Audited standalone and consolidated financial results for the fourth quarter as well as year ended 31.03.2024 along with the auditor report statement of assets and liabilities cash flow statement.2. Declaration regarding unmodified opinion of the auditors on annual audited audited financial results.3. Re- Appointment of Internal Auditor.4. Re-Appointment of Secretarial Auditor.5. Other routine business with the permission of the chair.
BSE 15-May-2024	Intimation FILE	Board Meeting Intimation for 01/2024-25 Board Meeting Of The Company Scheduled To Be Held On Thursday 23Rd Day Of May 2024 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 MEDI-CAPS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve 1. The Standalone as well as Consolidated Audited Financial Results of the Company for the fourth quarter as well as financial year ended on 31st March 2024 along with auditors report thereon.2. Other routine matters with the permission of chair.
BSE 11-May-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation regarding issue of duplicate share certificate and stop transfer of shares as per enclosed letter.

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
No Insider trading details found

BULK BLOCK DEALS FOR MEDI-CAPS LTD

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 05-Apr-2024	Buy BULK	79,371 @ 50.03	DHEERAJ KUMAR LOHIA
BSE 05-Apr-2024	Sell BULK	86,519 @ 50.48	GOPAL KRISHNA MAHESHWARI
BSE 03-Mar-2023	Buy BULK	62,449 @ 38.37	KANWARINDERPAL SAHNI
BSE 03-Mar-2023	Sell BULK	98 @ 39.70	KANWARINDERPAL SAHNI

DIVIDEND BY MEDI-CAPS LTD

No dividend details found

SPLIT / BONUS BY MEDI-CAPS LTD

No Split / Bonus details found

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

MEDI-CAPS LTD

MEDI-CAPS LTD share price

CONSOLIDATED QUARTERLY RESULT FOR MEDI-CAPS LTD

STANDALONE QUARTERLY RESULT FOR MEDI-CAPS LTD

CONSOLIDATED ANNUAL RESULT FOR MEDI-CAPS LTD

STANDALONE ANNUAL RESULT FOR MEDI-CAPS LTD

CONSOLIDATED PROFIT / LOSS FOR MEDI-CAPS LTD

STANDALONE PROFIT / LOSS FOR MEDI-CAPS LTD

CONSOLIDATED CASH FLOW FOR MEDI-CAPS LTD

STANDALONE CASH FLOW FOR MEDI-CAPS LTD

CONSOLIDATED BALANCE SHEET FOR MEDI-CAPS LTD

STANDALONE BALANCE SHEET FOR MEDI-CAPS LTD

FINANCIAL RATIOS (CONSOLIDATED) FOR MEDI-CAPS LTD

FINANCIAL RATIOS (STANDALONE) FOR MEDI-CAPS LTD

SHARE HOLDING PATTERN FOR MEDI-CAPS LTD

PEER COMPARISON FOR MEDI-CAPS LTD

CORPORATE ACTIONS FOR MEDI-CAPS LTD

CORPORATE ANNOUNCEMENTS FOR MEDI-CAPS LTD

INSIDER TRADING FOR MEDI-CAPS LTD

BULK BLOCK DEALS FOR MEDI-CAPS LTD

DIVIDEND BY MEDI-CAPS LTD

SPLIT / BONUS BY MEDI-CAPS LTD